Venus Remedies Ltd.

NSE : VENUSREM

₹457.3

11.6 (2.6%) - 14 Jun 2025 04:20 PM

NSE : VENUSREM

About Company

Venus Remedies Limited is a research and innovation-driven Indian pharmaceutical company with a global footprint in many nations. The company has several manufacturing facilities, hundreds of market authorisations, many global patents and product basket. Its GLP-accredited Venus Medicine Research Centre (VMRC) is committed to offering the world novel breakthroughs catering to the critical care and super specialty segments. Its manufacturing facilities deliver world-class products accepted by regulators in advanced and developing pharmaceutical markets.

Market Cap. ₹ 611 Cr.

52 Week - High/Low ₹ 477/270

P/E Ratio 11.63

P/B Ratio 1.20

Enterprise Value ₹ 574 Cr.

ROE % 6.18

RSI Value -

EMA 50 371.34

EMA 200 334.76

Market Cap. ₹ 611 Cr.

52 Week - High/Low ₹ 477/270

P/E Ratio 13.49